Dana Investment Advisors, Inc. Coherus Bio Sciences, Inc. Transaction History

Dana Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$14.43 - $19.16 $1.35 Million - $1.8 Million	-93,814 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$11.67 - $22.53 $753,076 - $1.45 Million	-64,531 Reduced 40.75%	93,814 $1.52 Million
Q4 2019 Feb 11, 2020	BUY	$16.33 - $21.37 $238,711 - $312,386	14,618 Added 10.17%	158,345 $2.85 Million
Q3 2019 Nov 12, 2019	BUY	$16.3 - $23.37 $2.34 Million - $3.36 Million	143,727 New	143,727 $2.91 Million

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.